Achieve Life Sciences, Inc. (ACHV) Stock Grade

About Achieve Life Sciences, Inc.'s fundamentals

Achieve Life Sciences is a biotechnology company with a market capitalization of $795.6 million that reported no year-over-year revenue growth and a net loss in its latest annual statement, resulting in a net margin of 0.0%. The company does not currently pay dividends to shareholders. As a pre-revenue or early-stage biotech firm, traditional valuation metrics like P/E ratio and return on equity are not applicable, which is typical for companies in development stages focused on bringing pipeline programs through clinical trials rather than generating near-term profits.